T-BAL CO., LTD.
Area: MOST Inno Zone
Booth No: N915
Website: https://www.t-bal.com
Exhibitor Profile
Novel design and manufacture with implementing VMND for cancer therapeutics
Control-released nanoparticle enable API (Active Pharmaceutical Ingredient) an alter drug distribution and pharmacokinetics, in which enable API more effectively delivered, less systemic complication, and enhanced targeting efficacy. The TBAL scientists discovered a novel lipoprotein VLDL-mimicking nanoparticle drug (VMND) encapsulating strategy which allow for cancer.
Brands
T-BAL CO., LTD.
Exhibitors you may be interested in
Highest Rated